In reviewed patients with recurrent weight gain or suboptimal response after bariatric surgery, semaglutide had significantly greater percentage total-weight-loss magnitude than liraglutide; the native coefficient, analyzed N and exposure were unstated.
In plain wordsAfter bariatric surgery with weight regain or suboptimal response, semaglutide produced greater percentage weight loss than liraglutide.
- Peptide
- Semaglutide
- Outcome
- IncreasePercentage total weight-loss magnitude
- Study
n: not reported in source
- Comparator
- liraglutide
- Outcome group
- Body weight · Metabolic and weight
- Studied dose
- Dose not stated
Source sentences
After subgroup analysis, we found that the effect of semaglutide on %TWL was significantly greater than that of liraglutide.
2 context sentences(design, population, supporting numbers)
We conducted a search of electronic databases, including Scopus, PubMed/Medline, and the Web of Science, up to December 2024.
The eligible studies included randomized controlled trials or retrospective studies that assessed the effects of obesity medications on weight, body mass index (BMI), or percentage total weight loss (%TWL) in patients experiencing recurrent weight gain or a suboptimal clinical response following bariatric surgery.